Les inscriptions sont ouvertes pour notre programme de 4 mois à temps plein, à Mila, conçu spécifiquement pour les fondateurs et fondatrices de la deep tech issus de parcours d'élite en STIM. Vous avez jusqu'au 21 novembre 2026 pour appliquer!
Offert par Mila et le Forum des politiques publiques, ce programme est conçu pour outiller les décideur·euse·s et les responsables des politiques publiques à naviguer efficacement à travers les opportunités et les risques liés à l'IA. La prochaine cohorte se tiendra en anglais les 5 et 6 novembre 2026 à Ottawa.
Le processus de demandes de supervision à Mila est maintenant ouvert! Vous pouvez appliquer dès maintenant à la maitrise de recherche ou Doctorat et joindre notre grande communauté de chercheur·euse·s à Mila pour l’automne 2027. Date limite : 1er décembre 2026
Nous utilisons des témoins pour analyser le trafic et l’utilisation de notre site web, afin de personnaliser votre expérience. Vous pouvez désactiver ces technologies à tout moment, mais cela peut restreindre certaines fonctionnalités du site. Consultez notre Politique de protection de la vie privée pour en savoir plus.
Paramètre des cookies
Vous pouvez activer et désactiver les types de cookies que vous souhaitez accepter. Cependant certains choix que vous ferez pourraient affecter les services proposés sur nos sites (ex : suggestions, annonces personnalisées, etc.).
Cookies essentiels
Ces cookies sont nécessaires au fonctionnement du site et ne peuvent être désactivés. (Toujours actif)
Cookies analyse
Acceptez-vous l'utilisation de cookies pour mesurer l'audience de nos sites ?
Lecteur Multimédia
Acceptez-vous l'utilisation de cookies pour afficher et vous permettre de regarder les contenus vidéo hébergés par nos partenaires (YouTube, etc.) ?
Publications
SIDISH integrates single-cell and bulk transcriptomics to identify high-risk cells and guide precision therapeutics through in silico perturbation
Single-cell RNA sequencing (scRNA-seq) provides high-resolution insights into cellular heterogeneity but remains costly, restricting its use… (voir plus) to small cohorts that often lack comprehensive clinical data, reducing translational relevance. In contrast, bulk RNA sequencing is scalable and cost-effective but obscures critical single-cell insights. We introduce SIDISH, a neural network framework that integrates the granularity of scRNA-seq with the scalability of bulk RNA-seq. Using a variational autoencoder, deep Cox regression, and transfer learning, SIDISH identifies high-risk cell populations while enabling robust clinical predictions from large-cohort data. Its in silico perturbation module identifies therapeutic targets by simulating interventions that reduce high-risk cells associated with adverse outcomes. SIDISH also generalizes to spatial transcriptomics, identifying high-risk cells and mapping them within their native tissue microenvironment. Applied across diverse diseases, SIDISH establishes the link between cellular dynamics and clinical phenotypes, facilitating biomarker discovery and precision medicine. By unifying single-cell insights with large-scale clinical data, SIDISH advances computational tools for disease risk assessment and therapeutic prioritization, offering an integrative and scalable approach to precision medicine. SIDISH integrates single-cell and bulk RNA sequencing data using deep learning to identify high-risk cell populations and prognostic biomarkers, enabling in silico perturbations that could guide precision therapeutics and advance personalized medicine.
Conformal Selection for Efficient and Accurate Compound Screening in Drug Discovery
Tian Bai
Peng Tang
Yuting Xu
Vladimir Svetnik
Bingjia Yang
Abbas Khalili
Xiang Yu
Archer Y. Yang
In drug discovery, the reliability of compound screening based on manual assessments is compromised by potential bias, while existing method… (voir plus)s lack robust risk control measures. To address these challenges, we introduced conformal selection as an enhanced approach to optimize the compound screening process with balanced risks and benefits. Leveraging conformal inference, our approach constructs p-values for each candidate molecule to quantify statistical evidence for selection. The final selection of molecules is determined by comparing these p-values against thresholds derived from multiple testing principles. Our approach offers rigorous control over the false discovery rate, ensuring validity independent of dataset size and requiring minimal assumptions. By avoiding the estimation of prediction errors required in previous approaches, our method achieves higher accuracy (power), thereby improving the ability to identify promising candidates. Furthermore, our method demonstrates superior computational efficiency. We validate these advantages through numerical simulations on real-world datasets.
2025-12-08
Journal of Chemical Information and Modeling (inconnu)
In this paper, we present a generalization of the certainty equivalence principle of stochastic control. One interpretation of the classical… (voir plus) certainty equivalence principle for linear systems with output feedback and quadratic costs is as follows: the optimal action at each time is obtained by evaluating the optimal state-feedback policy of the stochastic linear system at the minimum mean square error (MMSE) estimate of the state. Motivated by this interpretation, we consider certainty equivalent policies for general (non-linear) partially observed stochastic systems and allow for any state estimate rather than restricting to MMSE estimates. In such settings, the certainty equivalent policy is not optimal. For models with Lipschitz cost and dynamics, we derive upper bounds on the sub-optimality of certainty equivalent policies in terms of expected error of the proposed estimator. We present several examples to illustrate the results.
In this paper, we investigate optimal control of network-coupled subsystems, where the coupling between the dynamics of the subsystems is re… (voir plus)presented by the adjacency or Laplacian matrix of a directed graph. Under the assumption that the coupling matrix is normal and the cost coupling is compatible with the dynamics coupling, we use the spectral decomposition of the coupling matrix to decompose the overall system into at most n systems with noise coupled dynamics and decoupled cost, where n is the size of the network. Furthermore, the optimal control input at each subsystem can be computed by solving n1 decoupled Riccati equations where n1 (n1 ≤ n) denotes the number of distinct eigenvalues of the coupling matrix, where complex conjugate pairs are not double-counted. A salient feature of the result is that the solution complexity depends on the number of distinct eigenvalues of the coupling matrix rather than the size of the network. Therefore, the proposed solution framework provides a scalable method for synthesizing and implementing optimal control laws for large-scale network-coupled subsystems.
Despite enormous interest in psychedelics for psychiatric interventions, potential underlying biological mechanisms remain unclear. Here, we… (voir plus) confirm that a single dose of psilocybin increases synaptic transmission in mouse medial prefrontal cortex. Using scRNA-sequencing, we identify cell-type specific mechanisms of sustained neuroplastic effects. We show that, 24h post-psilocybin, expression of plasticity-related genes is increased in excitatory neurons and that transcription in a type of deep layer near projecting neuron, L5/6 NP, is robustly altered. Analyzing receptor expression patterns reveals that this cell-type specificity does not align with 5-HT
2A
expression but aligns with 5-HT
2C
expression patterns. Further, multivariate analyses identify psilocybin-induced gene expression patterns in L5/6 NP neurons predict 5-HT
2C
, but not 5-HT
2A
, transcript levels. Pharmacologic manipulation with a 5-HT
2C
antagonist attenuates the post-acute sustained effect of psilocybin on synaptic transmission, highlighting 5-HT
2C
signaling and L5/6 NP neurons as key mediators of psychedelic drug action’s sustained neuroplastic effects in mPFC.
Spatial transcriptomics has revolutionized our ability to characterize tissues and diseases by contextualizing gene expression with spatial … (voir plus)organization. Available methods require researchers to either train a model using histology-based annotations or use annotation-free clustering approaches to uncover spatial domains. However, few methods provide researchers with a way to jointly analyze spatial data from both annotation-free and annotation-guided perspectives using consistent inductive biases and levels of interpretability. A single framework with consistent inductive biases ensures coherence and transferability across tasks, reducing the risks of conflicting assumptions. To this end, we propose the Spatial Topic Model (SpaTM), a topic-modeling framework capable of annotation-guided and annotation-free analysis of spatial transcriptomics data. SpaTM can be used to learn gene programs that represent histology-based annotations while providing researchers with the ability to infer spatial domains with an annotation-free approach if manual annotations are limited or noisy. We demonstrate SpaTM’s interpretability with its use of topic mixtures to represent cell states and transcriptional programs and how its intuitive framework facilitates the integration of annotation-guided and annotation-free analyses of spatial data with downstream analyses such as cell type deconvolution. Finally, we demonstrate how both approaches can be used to extend the analysis of large-scale snRNA-seq atlases with the inference of cell proximity and spatial annotations in human brains with Major Depressive Disorder.
This is the Second Key Update to the 2025 International AI Safety Report. The First Key Update (1) discussed developments in the capabilitie… (voir plus)s of general-purpose AI models and systems and associated risks. This Key Update covers how various actors, including researchers, companies, and governments, are approaching risk management and technical mitigations for AI.
The past year has seen important developments in AI risk management, including better techniques for training safer models and monitoring their outputs. While this represents tangible progress, significant gaps remain. It is often uncertain how effective current measures are at preventing harms, and effectiveness varies across time and applications. There are many opportunities to further strengthen existing safeguard techniques and to develop new ones.
This Key Update provides a concise overview of critical developments in risk management practices and technical risk mitigation since the publication of the 2025 AI Safety Report in January. It highlights where progress is being made and where gaps remain. Above all, it aims to support policymakers, researchers, and the public in navigating a rapidly changing environment, helping them to make informed and timely decisions about the governance of general-purpose AI.
Professor Yoshua BengioUniversité de Montréal / LawZero /Mila – Quebec AI Institute & Chair